Leelyn Smith, LLC Gilead Sciences, Inc. Transaction History

Leelyn Smith, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $36,457 - $52,339	585 Added 508.7%	700 $60,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $74,127 - $84,672	-1,245 Reduced 91.54%	115 $7,000
Q2 2022 Aug 09, 2022	BUY	$57.72 - $65.01 $78,210 - $88,088	1,355 Added 27100.0%	1,360 $84,000
Q2 2021 Aug 31, 2021	SELL	$63.47 - $69.35 $4,696 - $5,131	-74 Reduced 93.67%	5 $0
Q3 2020 Nov 05, 2020	BUY	$62.1 - $78.08 $4,905 - $6,168	79 New	79 $5,000
Q2 2020 Aug 06, 2020	SELL	$72.34 - $84.0 $361 - $420	-5 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$61.62 - $67.78 $308 - $338	5 New	5 $0

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Leelyn Smith, LLC, based on Form 13F filings with the SEC.

Stay updated on Leelyn Smith, LLC with notifications on news.